2013년 한국뇌졸중진료지침 개정과 근거에 대한 고찰

키워드

참고문헌 (58)

1. Hong KS, "Epidemiology and Risk Factors : A Report from the Korean Stroke Society and Clinical Research Center for Stroke", J Stroke, 15, pp.2~20 (2013)
2. "OECD Economic Surveys: Korea 2010"[URL]
3. 배희준, "뇌졸중의 역학: 2006년 최신지견", 대한뇌졸중학회지, 9(1), pp.5~10 (2007), 대한뇌졸중학회
4. The writing group of clinical practice guideline for stroke, "Clinical Practice Guideline for Stroke. 1st ed" (2009), Clinical Research Center for Stroke
5. Agency for Health Care Policy and Research. Acute pain management: operative or medical procedures and trauma, "United States Department of Health and Human Services", AHCPR, 107~, pp.AHCPR publication No 92-0023 (1993)
6. 구자성, "한국뇌졸중진료지침에서 아스피린의 뇌졸중 일차예방효과에 관한 내용의 부분개정", 대한신경과학회지, 29(4), pp.277~284 (2011), 대한신경과학회
7. 김한영, "무증상경동맥협착의 치료: 2012년 한국뇌졸중일차예방 진료지침 부분개정", 대한신경과학회지, 30(2), pp.77~87 (2012), 대한신경과학회[DOI]
8. The writing group of clinical practice guideline for stroke, "Clinical Practice Guideline for Stroke. 2nd ed" (2012), Clinical Research Center for Stroke
9. 권형민, "2009년 한국 뇌졸중 진료지침에서 이차예방을 위한 항혈소판제의 사용에 관한 내용의 부분 개정", 대한신경과학회지, 28(2), pp.81~84 (2010), 대한신경과학회
10. 정근화, "2009년 한국 뇌졸중 진료지침에서 뇌졸중 이차예방 중 두개강외 경동맥협착의 수술 또는 중재적 치료에 관한 내용의 부분 개정", 대한뇌졸중학회지, 13(3), pp.99~106 (2011), 대한뇌졸중학회
11. 박태환, "뇌졸중 이차예방을 위한 항혈소판제의 사용: 2012년 한국 뇌졸중 이차예방 진료지침 부분 개정", 대한뇌졸중학회지, 14(1), pp.1~5 (2012), 대한뇌졸중학회[DOI]
12. The writing group of clinical practice guideline for stroke, "Clinical Practice Guideline for Stroke. 3rd ed" (2013), Clinical Research Center for Stroke
13. 박종무, "한국 뇌졸중 진료지침에서 심방세동 환자의 뇌졸중 일차예방에 관한 내용의 부분 개정", 대한뇌졸중학회지, 14(3), pp.106~115 (2012), 대한뇌졸중학회[DOI]
14. 서대희, "비파열뇌동맥류 진료지침 - 종설 -", Journal of Cerebrovascular and Endovascular Neurosurgery, 13(4), pp.279~290 (2011), 대한뇌혈관외과학회
15. 조경희, "한국 뇌졸중 진료지침 급성기 치료 중 혈전용해술에 대한 내용의 부분개정", 대한뇌졸중학회지, 14(3), pp.95~105 (2012), 대한뇌졸중학회[DOI]
16. Belch J, "The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease", BMJ, 337, pp.1840~ (2008)
17. Ogawa H, "Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial", JAMA, 300, pp.2134~2141 (2008)
18. Fowkes FG, "Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index : a randomized controlled trial", JAMA, 303, pp.841~848 (2010)
19. De Berardis G, "Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials", BMJ, 339, pp.4531~ (2009)
20. Zhang C, "Aspirin for primary prevention of cardiovascular events in patients with diabetes : A meta-analysis", Diabetes Res Clin Pract, 87, pp.211~218 (2010)
21. Berger JS, "Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease : a meta-analysis of randomized trials", JAMA, 301, pp.1909~1919 (2009)
22. Baigent C, "Aspirin in the primary and secondary prevention of vascular disease : collaborative meta-analysis of individual participant data from randomised trials", Lancet, 373, pp.1849~1860 (2009)
23. Brott TG, "Stenting versus endarterectomy for treatment of carotid-artery stenosis", N Engl J Med, 363, pp.11~23 (2010)
24. Halliday A, "10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis(ACST-1) : a multicentre randomised trial", Lancet, 376, pp.1074~1084 (2010)
25. Abbott AL., "Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis", Stroke, 40, pp.573~583 (2006)
26. Marquardt L, "Low risk of ipsilateral stroke in patients with asymptomatic carotid stenosis on best medical treatment: a prospective, population-based study", Stroke, 41, pp.11~17 (2010)
27. Goldstein LB, "Guidelines for the primary prevention of stroke : a guideline for healthcare professionals from the American Heart Association", American Stroke Association, 2011, pp.42, 517~584
28. European Stroke Organisation (ESO) Executive Committee, "ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008", Cerebrovasc Dis, 25, pp.457~507 (2008)
29. Brott TG HJ, "Guideline on the management of patients with extracranial carotid and vertebral artery disease", Stroke, 42, pp.464~540 (2011)
30. Connolly SJ, "Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation", N Engl J Med, 360, pp.2066~2078 (2009)
31. Connolly SJ, "Dabigatran versus Warfarin in Patients with Atrial Fibrillation", N Engl J Med, 361, pp.1139~1151 (2009)
32. Patel MR, "Rivaroxaban versus warfarin in nonvalvular atrial fibrillation", N Engl J Med, 365, pp.883~891 (2011)
33. Connolly SJ, "Apixaban in Patients with Atrial Fibrillation", N Engl J Med, 364, pp.806~817 (2011)
34. Granger CB, "Apixaban versus warfarin in patients with atrial fibrillation", N Engl J Med, 365, pp.981~992 (2011)
35. Bor AS, "Optimal screening strategy for familial intracranial aneurysms : a cost-effectiveness analysis", Neurology, 74, pp.1671~1679 (2010)
36. Schievink WI, "Intracranial aneurysms", N Engl J Med, 336, pp.28~40 (1997)
37. Wiebers DO, "Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment", Lancet, 362, pp.103~110 (2003)
38. Morita A, "The natural course of unruptured cerebral aneurysms in a Japanese cohort", N Engl J Med, 366, pp.2474~2482 (2012)
39. Molyneux AJ, "International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion", Lancet, 366, pp.809~817 (2005)
40. Molyneux AJ, "Risk of recurrent subarachnoid haemorrhage, death, or dependence and standardised mortality ratios after clipping or coiling of an intracranial aneurysm in the International Subarachnoid Aneurysm Trial (ISAT): long-term follow-up", Lancet Neurol, 8, pp.427~433 (2009)
41. Hacke W, "Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke", N Engl J Med, 359, pp.1317~1329 (2008)
42. ) : a randomised controlled trial, "Lancet", 2012, 2352~2363
43. Wardlaw JM, "Recombinant tissue plasminogen activator for acute ischaemic stroke : an updated systematic review and metaanalysis", Lancet, 379, pp.2364~2372 (2012)
44. Lee M, "Efficacy of intra-arterial fibrinolysis for acute ischemic stroke : meta-analysis of randomized controlled trials", Stroke, 41, pp.932~937 (2010)
45. Nogueira RG, "Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke(TREVO 2) : a randomised trial", Lancet, 380, pp.1231~1240 (2012)
46. Saver JL, "Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel- group, non-inferiority trial", Lancet, 380, pp.1241~1249 (2012)
47. Furlan A, "Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism", JAMA, 282, pp.2003~2011 (1999)
48. Sacco RL, "Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke", N Engl J Med, 359, pp.1238~1251 (2008)
49. Shinohara Y, "Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial", Lancet Neurol, 9, pp.959~968 (2010)
50. Kamal AK, "Cilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial origin", Cochrane Database Syst Rev, pp.008076~ (2011)
51. Huang Y, "Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double- blind, pilot study", Lancet Neurol, 7, pp.494~499 (2008)
52. Eckstein HH, "Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trial", Lancet Neurol, 7, pp.893~902 (2008)
53. Mas JL, "Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial: results up to 4 years from a randomised, multicentre trial", Lancet Neurol, 7, pp.885~892 (2008)
54. Ederle J, "Endovascular treatment with angioplasty or stenting versus endarterectomy in patients with carotid artery stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study(CAVATAS) : long-term follow-up of a randomised trial", Lancet Neurol, 8, pp.898~907 (2009)
55. Gurm HS, "Long-term results of carotid stenting versus endarterectomy in high-risk patients", N Engl J Med, 358, pp.1572~1579 (2008)
56. Ederle J, "Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis(International Carotid Stenting Study) : an interim analysis of a randomised controlled trial", Lancet, 375, pp.985~997 (2010)
57. Bonati LH, "Short-term outcome after stenting versus endarterectomy for symptomatic carotid stenosis : a preplanned meta-analysis of individual patient data", Lancet, 376, pp.1062~1073 (2010)
58. Bonati LH, "Long-term risk of carotid restenosis in patients randomly assigned to endovascular treatment or endarterectomy in the Carotid and Vertebral Artery Transluminal Angioplasty Study(CAVATAS) : long-term follow-up of a randomised trial", Lancet Neurol, 8, pp.908~917 (2009)

관련 논문AI추천